U.S. Gamma Knife Market Size, Share & Trends Analysis Report By Indication (Malignant Tumors, Benign Tumors, Vascular Disorders, Functional Disorders, Ocular Diseases), And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Indication
                        1.2.2. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                            1.4.5.1. Data for primary interviews in U.S.
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Indication Outlook
                    2.3. Competitive Insights
Chapter 3. U.S. Gamma Knife Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                            3.2.1.1. Increasing prevalence of neurological diseases
                            3.2.1.2. Growing gamma knife adoption and preference
                            3.2.1.3. Technological advancements
                            3.2.1.4. Evolution of minimally invasive surgery options
                        3.2.2. Market restraint analysis
                            3.2.2.1. High treatment cost
                            3.2.2.2. Fluctuating reimbursements
                    3.3. U.S. Gamma Knife Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s Five Forces
                            3.3.1.1. Threat of new entrant
                            3.3.1.2. Threat of substitues
                            3.3.1.3. Bargaining power of buyers
                            3.3.1.4. Bargaining power of suppliers
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political & legal landscape
                            3.3.2.2. Economic landscape
                            3.3.2.3. Social landscape
                            3.3.2.4. Technological landscape
                            3.3.2.5. Environmental landscape
Chapter 4. U.S. Gamma Knife: Mobility Estimates & Trend Analysis
                    4.1. U.S. Gamma Knife Market: Indication Dashboard
                    4.2. U.S. Gamma Knife Market: Indication Movement Analysis
                    4.3. U.S. Gamma Knife Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                    4.4. Malignant Tumors
                        4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.5. Benign Tumors
                        4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.6. Vascular Disorders
                        4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.7. Functional Disorders
                        4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.8. Ocular Diseases
                        4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Competitive Landscape
                    5.1. Recent Developments & Impact Analysis, By Key Market Participants
                    5.2. Company/Competition Categorization
                    5.3. Vendor Landscape
                        5.3.1. List of key distributors and channel partners
                        5.3.2. Key customers
                        5.3.3. Key company market share analysis, 2023
                        5.3.4. Elekta AB
                            5.3.4.1. Company overview
                            5.3.4.2. Financial performance
                            5.3.4.3. Product benchmarking
                            5.3.4.4. Strategic initiatives
                        5.3.5. Varian Medical Systems
                            5.3.5.1. Company overview
                            5.3.5.2. Financial performance
                            5.3.5.3. Product benchmarking
                            5.3.5.4. Strategic initiatives
                        5.3.6. Huiheng Medical, Inc.
                            5.3.6.1. Company overview
                            5.3.6.2. Financial performance
                            5.3.6.3. Product benchmarking
                            5.3.6.4. Strategic initiatives
                        5.3.7. MASEP Medical Science Technology Development (Shenzhen) Co., Ltd.
                            5.3.7.1. Company overview
                            5.3.7.2. Financial performance
                            5.3.7.3. Product benchmarking
                            5.3.7.4. Strategic initiatives
                        5.3.8. Akesis Inc.
                            5.3.8.1. Company overview
                            5.3.8.2. Financial performance
                            5.3.8.3. Product benchmarking
                            5.3.8.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 U.S. Gamma Knife Market, by Indication, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 U.S. gamma knife market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 End-use and end-use segment snapshot
Fig. 10 Sales channel and age segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Market dynamics
Fig. 13 Porter’s Five Forces analysis
Fig. 14 PESTLE analysis
Fig. 15 U.S. gamma knife market: Indication outlook and key takeaways
Fig. 16 U.S. gamma knife market: Indication movement analysis
Fig. 17 Malignant tumors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Benign tumors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Vascular disorders market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Functional disorders market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Ocular diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Company market share analysis, 2023
Fig. 23 Strategic framework